Abstract

Cancer pain represents a complex and challenging aspect of the oncology spectrum, significantly impacting the quality of life for patients undergoing cancer treatment. This abstract provides a concise overview of various therapeutic interventions aimed at effectively managing malignant growth-related pain. The multifaceted nature of cancer pain necessitates a comprehensive approach, combining pharmacological, interventional, and complementary modalities. Pharmacotherapy remains a cornerstone, with opioid analgesics playing a central role in alleviating moderate to severe pain. However, the judicious use of adjuvant medications, such as no steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, and antidepressants, contributes to a more nuanced and personalized pain management strategy.